In addition, the plasma XOR activity also tended to be decreased in patients with diabetic retinopathy (60.3 pmol/h/mL (18.0–123)) as compared to those without diabetic retinopathy (77.2 pmol/h/mL (36.2–213)), although the difference did not reach statistical significance.
← all excerpts
Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes.
1
—
—